[Molecular mechanisms of lymphatic development].
Kubo
Hajime
H
Molecular & Cancer Research Unit, HMRO, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
D042702:Angiopoietin-2 / Q000502:physiology; D000818:Animals; D002454:Cell Differentiation / Q000235:genetics; D004487:Edema / Q000235:genetics / Q000628:therapy; D042783:Endothelial Cells / Q000166:cytology; D006801:Humans; D020104:Immunophilins / Q000502:physiology; D042583:Lymphangiogenesis / Q000235:genetics*; D008206:Lymphatic Diseases / Q000235:genetics / Q000628:therapy; D008207:Lymphatic Metastasis / Q000235:genetics / Q000517:prevention & control; D042601:Lymphatic Vessels / Q000166:cytology / Q000196:embryology; D009154:Mutation; D042582:Vascular Endothelial Growth Factor C / Q000502:physiology; D042643:Vascular Endothelial Growth Factor D / Q000502:physiology; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000502:physiology
D042702:Angiopoietin-2; D042582:Vascular Endothelial Growth Factor C; D042643:Vascular Endothelial Growth Factor D; D040321:Vascular Endothelial Growth Factor Receptor-3; D020104:Immunophilins